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A large number of general population studies that compare all-cause mortality across
established body mass index (BMI; weight(kg)/height(m) squared) categories have found
slightly lower all-cause mortality among those with BMI 25-<30 (overweight) than among
those with a BMI of 18.5-<25 (normal weight).(1) The association of BMI with mortality
appears to vary by age and other factors. In the general population, at younger ages there is
often a curvilinear relation between BMI and mortality, with the lowest mortality sometimes
found at BMI values toward the upper end of the normal weight category. This can lead to
similar or slightly lower mortality in the overweight category (BMI 25-<30) than in the full
range of the normal weight category (BMI 18.5-<25). In the elderly, low BMI is often
associated with higher mortality, while higher BMI levels appear either to have no
association with higher mortality or even to provide some survival advantage.(2)
In individuals with chronic disease states such as heart failure, chronic kidney disease or
chronic obstructive pulmonary diseases, the BMI-mortality association is either reverse J
shape or inverse with higher BMI categories associated with greater survival.(3) This
phenomenon is sometimes known as the “obesity paradox” or “reverse epidemiology,” a
term also used for similar alterations in risk-factor-survival patterns for other cardiovascular
risks as hypercholesterolemia. Although the observation of improved survival in heavier
patients was not new, the specific term “obesity paradox” seems to have first been used by
Gruberg et al. in 2002(4), who found that among patients with coronary artery disease who
underwent percutaneous coronary intervention, very lean patients and those with BMI
within the normal range were at the highest risk for in-hospital complications, cardiac death
and one-year mortality. Modestly improved survival among overweight patients relative to
normal weight patients has repeatedly been observed in diverse situations, for example in a
review of findings in the surgical population(5), in a meta-analysis of acutely ill patients (6)
and in a study of driver mortality in vehicle crashes.(7)
All-cause mortality reflects the net effect of incidence and survival across all causes of
death. Although overweight is a risk factor for certain medical conditions, including
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coronary heart disease, diabetes and some types of cancer, the relative risk for mortality
from these conditions among the overweight is not necessarily as high as the relative risk for
incidence. In addition, some medical conditions leading to mortality may have little or no
association with higher weight, and some conditions leading to mortality, such as lung
cancer or hip fracture, appear to be inversely related to BMI.(8) (9) The association of
overweight with modestly increased survival across many conditions could result in a net
decrease in the risk of all-cause mortality associated with overweight.
Hypothetical scenarios have been put forward to explain these oft-repeated epidemiologic
findings in the general population of similar or lower mortality among the overweight
relative to normal weight as being due to bias from smoking or pre-existing illness. It is
sometimes argued that the increased mortality risk at low BMI levels among smokers is
evidence of residual confounding by unmeasured aspects of smoking, but the same
phenomenon of increased mortality risk at low BMI levels is seen among never smokers (10,
11) making residual confounding an unlikely explanation. Former smoking has little or no
association with BMI levels (10, 11) and is thus an even less likely source of residual
confounding. Similarly little evidence exists to show that illness-related weight loss is a
source of bias or to identify the possible direction or magnitude of any bias.(12) Deletion of
the first few years of mortality, a maneuver suggested to at least partially adjust for possible
illness-related weight losses, has generally been shown to have little or no effect on the
results. (13) Researchers sometimes delete the majority of deaths (70 to 90 percent) in a
sample to address these putative biases. The deletion of such a large proportion of the
sample may itself increase bias, although in many studies such deletions have been found to
have little or no effect on the results (1)
A more parsimonious explanation for the mortality advantage seen among overweight
people is that overweight people have modest survival advantages in a wide variety of
adverse situations that are not outweighed by the increased risk of some medical conditions.
The repeated observations of curvilinear relations at younger ages and null to inverse
relations at older ages are consistent with the evolving body of research suggesting that for
patients with a variety of conditions, survival may be slightly better for the heavier patients.
Many of these studies are clinical studies or analyses of registry data and thus based on
patients whose medical history and severity of illness are well characterized, making bias
from undiagnosed illness less likely.
The underlying reasons for the increased survival among overweight and even obese
patients have not been well elucidated. Potential suggestions include both physiologic and
behavioral factors. Some research suggests that overweight and obese patients may receive
better medical treatment (14), but other studies suggest they may receive less appropriate
treatment (15); this might vary by medical condition or other factors. Lean people who
develop conditions such as hypertension or diabetes mellitus may have more severe forms of
the disease than obese people. As a result, mortality risk estimates derived from lean people
with these conditions may overestimate the mortality risk among heavier people with those
conditions. Suggested physiological mechanisms have included endocrine effects of adipose
tissue, cardioprotective effects of leptin and adiponectin, and increased lean body mass and
fat mass in heavier patients.
The all-cause mortality advantage seen in mildly overweight people in observational studies
in the general population is small but consistent. The extensive literature on the modest
survival benefits of overweight in a variety of adverse situations, including chronic and
acute illness and medical procedures, supports and reinforces the findings of the general
population studies.
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